-
Je něco špatně v tomto záznamu ?
Evaluation of cytokines and soluble adhesion molecules in patients with newly diagnosed acute myeloid leukemia: the role of TNF-alpha and FLT3-ITD
T. Kupsa, J. Vanek, M. Vasatova, I. Karesova, P. Zak, L. Jebavy, J. M. Horacek
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
26365931
DOI
10.5507/bp.2015.036
Knihovny.cz E-zdroje
- MeSH
- akutní myeloidní leukemie krev farmakoterapie MeSH
- analýza hlavních komponent MeSH
- chemorezistence MeSH
- cytokiny metabolismus MeSH
- lidé středního věku MeSH
- lidé MeSH
- molekuly buněčné adheze metabolismus MeSH
- počet leukocytů MeSH
- prospektivní studie MeSH
- protokoly protinádorové kombinované chemoterapie terapeutické užití MeSH
- TNF-alfa fyziologie MeSH
- tyrosinkinasa 3 podobná fms fyziologie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVES: Acute myeloid leukemia (AML) cells are highly resistant to therapy. The presumed molecular basis of this resistance is the effect of tumor necrosis factor alpha (TNF-α) and other cytokines on endothelial adhesion molecule expression. The aim of this study was to test the hypothesis that cytokines and soluble adhesion molecules correlate in AML. METHODS: Baseline serum levels of 17 cytokines and 5 soluble adhesion molecules were measured in 53 AML patients using biochip array technology. Age, leukocyte count, secondary AML, CRP, FLT3-ITD and remission were variables. Statistical analysis was performed in R version 3.1.2. RESULTS: VCAM-1 correlated with ICAM-1 (P < 0.0001), E-selectin (P < 0.0001), leukocyte count (P = 0.0005) and TNF-α (P = 0.0035). E-selectin correlated with leukocyte count (P < 0.0001), P-selectin (P = 0.0032) and MCP-1 (P = 0.0119). CRP correlated with IL-6 (P < 0.0001), leukocyte count negatively correlated with IL-7 (P = 0.0318). FLT3-ITD was associated with higher E-selectin (P = 0.0010) and lower IL-7 (P = 0.0252). Secondary AML patients were older. Failure of induction therapy was associated with significantly higher CRP and lower P-selectin. Leukocyte count (P < 0.0001), FLT3-ITD (P = 0.0017) and secondary AML (P = 0.0439) influenced the principal component. CONCLUSIONS: Leukemic cells can modulate the microenvironment. Cytokine, adhesion molecule levels and leukocyte count correlate in AML. Understanding these mechanisms may form the basis of novel therapeutic approaches.
Institute of Clinical Biochemistry and Diagnostics University Hospital Hradec Kralove Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17006146
- 003
- CZ-PrNML
- 005
- 20200211141154.0
- 007
- ta
- 008
- 170210s2016 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2015.036 $2 doi
- 035 __
- $a (PubMed)26365931
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Kupsa, Tomáš $u Department of Military Internal Medicine and Military Hygiene, University of Defence, Faculty of Military Health Sciences, Hradec Kralove, Czech Republic; 4th Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Czech Republic $7 xx0267991
- 245 10
- $a Evaluation of cytokines and soluble adhesion molecules in patients with newly diagnosed acute myeloid leukemia: the role of TNF-alpha and FLT3-ITD / $c T. Kupsa, J. Vanek, M. Vasatova, I. Karesova, P. Zak, L. Jebavy, J. M. Horacek
- 520 9_
- $a OBJECTIVES: Acute myeloid leukemia (AML) cells are highly resistant to therapy. The presumed molecular basis of this resistance is the effect of tumor necrosis factor alpha (TNF-α) and other cytokines on endothelial adhesion molecule expression. The aim of this study was to test the hypothesis that cytokines and soluble adhesion molecules correlate in AML. METHODS: Baseline serum levels of 17 cytokines and 5 soluble adhesion molecules were measured in 53 AML patients using biochip array technology. Age, leukocyte count, secondary AML, CRP, FLT3-ITD and remission were variables. Statistical analysis was performed in R version 3.1.2. RESULTS: VCAM-1 correlated with ICAM-1 (P < 0.0001), E-selectin (P < 0.0001), leukocyte count (P = 0.0005) and TNF-α (P = 0.0035). E-selectin correlated with leukocyte count (P < 0.0001), P-selectin (P = 0.0032) and MCP-1 (P = 0.0119). CRP correlated with IL-6 (P < 0.0001), leukocyte count negatively correlated with IL-7 (P = 0.0318). FLT3-ITD was associated with higher E-selectin (P = 0.0010) and lower IL-7 (P = 0.0252). Secondary AML patients were older. Failure of induction therapy was associated with significantly higher CRP and lower P-selectin. Leukocyte count (P < 0.0001), FLT3-ITD (P = 0.0017) and secondary AML (P = 0.0439) influenced the principal component. CONCLUSIONS: Leukemic cells can modulate the microenvironment. Cytokine, adhesion molecule levels and leukocyte count correlate in AML. Understanding these mechanisms may form the basis of novel therapeutic approaches.
- 650 _2
- $a protokoly protinádorové kombinované chemoterapie $x terapeutické užití $7 D000971
- 650 _2
- $a molekuly buněčné adheze $x metabolismus $7 D015815
- 650 _2
- $a cytokiny $x metabolismus $7 D016207
- 650 _2
- $a chemorezistence $7 D019008
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a akutní myeloidní leukemie $x krev $x farmakoterapie $7 D015470
- 650 _2
- $a počet leukocytů $7 D007958
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a analýza hlavních komponent $7 D025341
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a TNF-alfa $x fyziologie $7 D014409
- 650 _2
- $a tyrosinkinasa 3 podobná fms $x fyziologie $7 D051941
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vaněk, Jan, $u Department of Informatics and Quantitative Methods, Faculty of Informatics and Management, University of Hradec Kralove, Czech Republic $d 1978- $7 xx0114510
- 700 1_
- $a Vašatová, Martina $u Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, Czech Republic $7 xx0135924
- 700 1_
- $a Karešová, Iva $u Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, Czech Republic $7 xx0207728
- 700 1_
- $a Žák, Pavel, $u 4th Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Czech Republic $d 1966- $7 mzk2006354145
- 700 1_
- $a Jebavý, Ladislav, $u Department of Military Internal Medicine and Military Hygiene, University of Defence, Faculty of Military Health Sciences, Hradec Kralove, Czech Republic; 4th Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Czech Republic $d 1950- $7 mzk2007408362
- 700 1_
- $a Horáček, Jan $u Department of Military Internal Medicine and Military Hygiene, University of Defence, Faculty of Military Health Sciences, Hradec Kralove, Czech Republic; 4th Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Czech Republic $7 xx0040415
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 160, č. 1 (2016), s. 94-99
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20170210 $b ABA008
- 991 __
- $a 20200211141548 $b ABA008
- 999 __
- $a ok $b bmc $g 1192629 $s 966793
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 160 $c 1 $d 94-99 $e 20150904 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20170210